| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |